Home » Newsletters » BioWorld Science

BioWorld Science

June 18, 1998

View Archived Issues

MitoKor and UCSF collaborate on Alzheimer's disease research

Guilford seeks licensing partner for Parkinson's disease diagnostic tool

Guilford offering two lead neuroprotective programs for licensing

Orally active and potent GH secretagogue discovered by Merck & Co.

Long-term financing plan for Genzyme Tissue Repair revealed

P&U identifies potent distamycin derivatives with improved therapeutic indices

Oncolym makes progress in phase II

Company Profile: Genome Pharmaceuticals

Final HOT Study results announced

Ebelactone B, a urinary kininase inhibitor, prevents salt-related hypertension in rats

Melatonin effective therapy for headache in patients with sleep phase delay syndrome

Antidiabetic activity of S-3483, a site-specific inhibitor of Glc-6-Pase

ABT-761: relationship between effect on exercise-induced bronchoconstriction and 5-LO inhibition

Dompe's novel antihistamine in phase I testing

Dual-action ACE/NEP inhibitors in the pipeline at Zambon

Research into new tocolytic agents continues at Merck & Co.

New HIV protease inhibitors reported by Searle

Kyowa Hakko claims new agents for thrombocytopenia

Irish research organization discovers MAO inhibitor with cytoprotective effects

Adolor in-licenses Roberts compound for narcotic-induced constipation

Abarelix poised to enter phase III clinical development

Famvir cleared by FDA for treatment of herpes in HIV-positive individuals

NDA submitted for new lung tumor imaging agent from Diatide

Angiotech's micellar paclitaxel enters clinic for arthritis

Second trial begins for DTI-136 in the treatment of liver cancer

Phase IIb results presented for pulmonary insulin

Zonagen reaches milestone for Vasomax

Karo Bio and the University of California expand license agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...